Deutsche Biotech-Unternehmen und ihre Innovationsfähigkeit im internationalen 
Vergleich: Eine institutionentheoretische Analyse

Lange, Knut Stefan Garrit

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Thesis

Deutsche Biotech-Unternehmen und ihre Innovationsfähigkeit im internationalen Vergleich: Eine institutionentheoretische Analyse

MPS-Authors

/persons/resource/persons41234

Lange, Knut Stefan Garrit
Wissenschaft, Technik und Innovationssysteme, MPI for the Study of Societies, Max Planck Society;

External Resource

http://irs.ub.rug.nl/ppn/292008961
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

mpifg_diss06_Lange.pdf
(Any fulltext), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Lange, K. S. G. (2006). Deutsche Biotech-Unternehmen und ihre Innovationsfähigkeit im internationalen Vergleich: Eine institutionentheoretische Analyse. PhD Thesis, University of Groningen, Groningen.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0012-4ACF-2

Abstract

Summary
1. Introduction
In the mid-1990s, legal changes and policy initiatives in Germany led to the rapid emergence of a biotechnology industry. Initially, German biotech companies focused on the market segment of platform technologies, characterized by incremental innovations. In recent years however, many companies have shifted their strategic focus on the market
segment of therapeutics, characterized by radical innovations. Since an active involvement in such a segment is untypical for German companies the central research question of this thesis was, if the German institutional framework allowed biotech companies to be internationally competitive in a radical-innovative market segment. The findings are particularly relevant for the literatures on “Varieties of Capitalism”, “National Innovation Systems” and for the sociology of technology. The British and the US biotech industry served as a comparison for the validation of the German case study.